Biotech4 hours ago
Chai Discovery Becomes a Unicorn with $130 Million Series B to Accelerate AI-Driven Drug Design
Chai Discovery, an OpenAI-backed biotech startup, raised $130 million in Series B funding, reaching a $1.3 billion valuation. Led by General Catalyst and Oak HC/FT, the...